• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Just Ask the Expert: Transitional cell carcinoma of the bladder and piroxicam

March 4, 2010
Timothy M. Fan, DVM, PhD, DACVIM (internal medicine, oncology)

Does piroxicam have any effect in cats with transitional cell carcinoma of the bladder?

Dr. Fan welcomes oncology questions from veterinarians and veterinary technicians.

E-mail:vm@advanstar.com

With the subject line: Oncology questions

Q: Does piroxicam have any effect in cats with transitional cell carcinoma of the bladder? If so, what is the recommended dosage?

A. Piroxicam is a mixed COX-1/COX-2 inhibitor that reduces the production of various inflammatory lipid mediators. Such lipid mediators, including prostaglandin E2, may favor the development and growth of tumors through various mechanisms, including the promotion of new blood vessel growth, immunosuppression, and reduced death signaling. Because of these effects, piroxicam has demonstrated modest activity in dogs with transitional cell carcinoma.1

The potential anticancer effects of piroxicam in cats with transitional cell carcinoma have not been thoroughly described,2 but, anecdotally, piroxicam appears to be well-tolerated at a dosage of 0.3 mg/kg by mouth two or three times a week.2 Using this dosing scheme in cats with transitional cell carcinoma should be safe based on prior pharmacokinetic studies of oral piroxicam conducted in healthy cats3,4; however, its anticancer effectiveness remains poorly characterized in cancer-bearing cats.

References

Advertisement

1. Knapp DW, Richardson RC, Chan TC, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994;8(4):273-278.

2. Wilson HM, Chun R, Larson VS, et al. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004). J Am Vet Med Assoc 2007;231(1):101-106.

3. Heeb HL, Chun R, Koch DE, et al. Single dose pharmacokinetics of piroxicam in cats. J Vet Pharmacol Ther 2003;26(4):259-263.

4. Heeb HL, Chun R, Koch DE, et al. Multiple dose pharmacokinetics and acute safety of piroxicam and cimetidine in the cat. J Vet Pharmacol Ther 2005;28(5):447-452. 

Timothy M. Fan, DVM, PhD, DACVIM (internal medicine and oncology)

Department of Veterinary Clinical Medicine

College of Veterinary Medicine

University of Illinois

Urbana, IL 61802

The intent of Just Ask the Expert is to address non-urgent medical questions and to share this information through the Web site with other practitioners. The recommendations are for informational purposes only. It is each clinician's responsibility to carefully weigh these recommendations and determine the right course of action for each patient. Please verify any drug dosages discussed. Questions may be edited for style and length.

Related Content:

Oncology
Morris Animal Foundation funds study on environmental toxins and lymphoma
Morris Animal Foundation funds study on environmental toxins and lymphoma
Superficial radiation therapy may serve as promising cutaneous MCT treatment
Superficial radiation therapy may serve as promising cutaneous MCT treatment
VolitionRx publishes new research in PLOS ONE
VolitionRx publishes new research in PLOS ONE

Advertisement

Latest News

I graduated veterinary school in 2023: Here are my takeaways

Life after coming out in veterinary medicine

Free microchipping event to take place in Chicago

Zoo announces birth of critically endangered red wolf pups

View More Latest News
Advertisement